C3 to raise $10m through underwritten share purchase plan

Perth-based burns treatment developer Clinical Cell Culture Ltd, or C3, will raise $10 million through a share purchase plan to existing shareholders for further commercialisation of the company's ReCell product.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byNorth Metro TAFE


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
50 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer